Publication | Closed Access

Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial

Interim AnalysisSurgical OncologyNeoadjuvant ChemotherapyMedicineMetronomic TherapyBronchial NeoplasmThoracic SurgerySurgeryCancer TreatmentOncologyRadiation OncologyLung CancerPerioperative TislelizumabRadiologyHealth Sciences